Scleromyxedema, a therapeutic dilemma

Julio Cesar Salas-Alanis; Brayant Martinez-Jaramillo; Minerva Gomez-Flores; Jorge Ocampo-Candiani

doi:10.4103/0019-5154.152600

Scleromyxedema, a therapeutic dilemma

Julio Cesar Salas-Alanis
, Brayant Martinez-Jaramillo
, Minerva Gomez-Flores
, Jorge Ocampo-Candiani

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.

Original language	English
Pages (from-to)	215
Number of pages	1
Journal	Indian Journal of Dermatology
Volume	60
Issue number	2
DOIs	https://doi.org/10.4103/0019-5154.152600
Publication status	Published - 1 Apr 2015

All Science Journal Classification (ASJC) codes

Dermatology

Access to Document

10.4103/0019-5154.152600

Cite this

@article{e93c7ce58c6242d693ea045eca38b4a9,

title = "Scleromyxedema, a therapeutic dilemma",

abstract = "Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.",

author = "Salas-Alanis, \{Julio Cesar\} and Brayant Martinez-Jaramillo and Minerva Gomez-Flores and Jorge Ocampo-Candiani",

year = "2015",

month = apr,

day = "1",

doi = "10.4103/0019-5154.152600",

language = "English",

volume = "60",

pages = "215",

journal = "Indian Journal of Dermatology",

issn = "0019-5154",

publisher = "Medknow Publications and Media Pvt. Ltd",

number = "2",

}

TY - JOUR

T1 - Scleromyxedema, a therapeutic dilemma

AU - Salas-Alanis, Julio Cesar

AU - Martinez-Jaramillo, Brayant

AU - Gomez-Flores, Minerva

AU - Ocampo-Candiani, Jorge

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.

AB - Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.

UR - https://www.scopus.com/pages/publications/84925402645

UR - https://www.scopus.com/pages/publications/84925402645#tab=citedBy

U2 - 10.4103/0019-5154.152600

DO - 10.4103/0019-5154.152600

M3 - Article

C2 - 25814746

SN - 0019-5154

VL - 60

SP - 215

JO - Indian Journal of Dermatology

JF - Indian Journal of Dermatology

IS - 2

ER -

Scleromyxedema, a therapeutic dilemma

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this